{{Rsnum
|rsid=2819742
|Gene=RYR2
|Chromosome=1
|position=237826822
|Orientation=plus
|GMAF=0.2185
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RYR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 19.5 | 40.7 | 39.8
| HCB | 0.0 | 13.9 | 86.1
| JPT | 0.0 | 8.0 | 92.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 3.5 | 19.3 | 77.2
| CHB | 0.0 | 13.9 | 86.1
| CHD | 0.9 | 11.0 | 88.1
| GIH | 2.0 | 35.0 | 63.0
| LWK | 0.0 | 1.8 | 98.2
| MEX | 8.6 | 48.3 | 43.1
| MKK | 0.6 | 9.0 | 90.4
| TSI | 16.8 | 47.5 | 35.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21386754
|Trait=None
|Title=Cerivastatin, genetic variants, and the risk of rhabdomyolysis
|RiskAllele=G
|Pval=2E-7
|OR=2.0800
|ORtxt=[1.59-2.78]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}